Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib

about

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib

Item

http://www.wikidata.org/entity/Q59138476

description

wetenschappelijk artikel

@nl

name

Comparative analysis of the So ...... nic phase patients on imatinib

@en

Comparative analysis of the So ...... nic phase patients on imatinib

@nl

type

Item

label

Comparative analysis of the So ...... nic phase patients on imatinib

@en

Comparative analysis of the So ...... nic phase patients on imatinib

@nl

prefLabel

Comparative analysis of the So ...... nic phase patients on imatinib

@en

Comparative analysis of the So ...... nic phase patients on imatinib

@nl

P1476

Comparative analysis of the So ...... nic phase patients on imatinib

@en

P2093

Haraprasad Pati

http://www.w3.org/2001/XMLSchema#string

Kanwaljeet Singh

http://www.w3.org/2001/XMLSchema#string

Manoranjan Mahapatra

http://www.w3.org/2001/XMLSchema#string

Rekha Chaubey

http://www.w3.org/2001/XMLSchema#string

Renu Saxena

http://www.w3.org/2001/XMLSchema#string

Seema Tyagi

http://www.w3.org/2001/XMLSchema#string

Sudha Sazawal

http://www.w3.org/2001/XMLSchema#string

Sunita Chhikara

http://www.w3.org/2001/XMLSchema#string

P2860

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.

Chronic myeloid leukemia data from India

The biology of chronic myeloid leukemia.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience.

Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

P304

258-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/SAJC.SAJC_244_17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30430096

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6190386

http://www.w3.org/2001/XMLSchema#string